EP
LMRI

Essential Partners’s Lumexa Imaging Holdings LMRI Stock Holding History

Essential Partners’s Portfolio LMRI Stock Details LMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451 Buy
+40
New +$365 ﹤0.01% 2498

Other funds holding LMRI

Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TI
Think Investments San Francisco, California $847M AUM 88.1% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Essential Partners's LMRI Position: Q2 2026 in Review

Essential Partners opened a new position in Lumexa Imaging Holdings (LMRI) in Q2 2026: 40 shares worth $451. The stake represents ﹤0.01% of the portfolio and ranks #2498 among its holdings.

103 funds tracked by Wall St. Rank hold LMRI as of Q2 2026.

  • Essential Partners held 40 shares of Lumexa Imaging Holdings worth $451 as of Q2 2026.
  • Lumexa Imaging Holdings was a new Essential Partners position in Q2 2026.
  • Lumexa Imaging Holdings made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2498 holding.
  • 103 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.